Pyrogen Testing Market | Growing Pharmaceutical, Biotechnology, and Medical Devices Industries

According to Precision Business Insights (PBI), the latest report the global pyrogen testing market is expected to be worth USD 1,348.3 million in 2021 and projected to grow at a 12.5% CAGR over 2022 to 2028. Chronic diseases are prevalent in highly developed nations and even more so in developing markets. Due to this, the need for pyrogen testing, as well as increased awareness, is predicted to develop rapidly throughout the projection period. North America should dominate the market share throughout the projection period due to the existence of well-developed healthcare organizations and well-defined laws and regulations for the pharmaceutical manufacturing process. Pyrogen testing is extremely useful in the evaluation of human-relevant airborne pyrogens in the case of airborne disorders such as chronic obstructive pulmonary disease and infantile asthma. These tests are also beneficial in identifying contamination caused by an inflammatory response in patients with chronic renal disease.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/pyrogen-testing-market/

The Assays, Kits, And Reagents Segment is Dominating the Pyrogen Testing Market:
The increasing mortality rate due to chronic disease has boosted the need for an urgent requirement for speedy diagnosis, which has accelerated the expansion of the reagents and test kits segments. According to the Centers for Disease Control and Prevention, infectious diseases such as malaria, TB, and AIDS/HIV account for almost half of all fatalities globally. According to National Cancer Institute data, more than 1 million new cancer cases were documented in the United States in 2016. These cases are fast increasing each year and are predicted to cause more than 5 million cancer cases in the forecast years.

North America Leads Pyrogen Testing Market:
North America is expected to hold a significant market share in the global pyrogen testing market and is projected to grow at a prominent growth rate over the forecast years due to its well-established healthcare infrastructure, superior regulatory framework, and the presence of biotechnological and biopharmaceutical companies across the regions North America is found to dominate the total market. Moreover, an increase in the frequency of chronic and infectious disorders across the Europe and Asia Pacific regions may significantly enhances the revenue of the market over the forecast years.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global Pyrogen Testing market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In May 2018, MilliporeSigma Announces Collaboration with Solvias, a Swiss contract research and service provider, to offer New Pyrogen Detection Kit.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=61624

The pyrogen testing market is segmented based on product & service, test type, end user and geography:
Based on the Product & Service, the market is segmented into the following:
• Assays, Kits, & Reagents
• Instruments
• Services

Based on the Test Type, the market is segmented into the following:
• LAL Tests
• In Vitro Tests
• Rabbit Tests

Based on the End User, the market is segmented into the following:
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Other End Users

Based on Geography, the market is segmented into the following:
• North America
• Europe
• Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=61624

Key player's profiles in the Pyrogen Testing Market report are Charles River Laboratories, Inc. (US), Lonza (Switzerland), Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US), Associates of Cape Cod, Inc. (US), GenScript Biotech Corporation (China), bioMérieux SA (France), Eurofins Scientific (Luxembourg), WuXi AppTec (China), Hycult Biotech (Netherlands).

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.